Document Type
Article
Publication Date
6-23-2022
Publication Title
PLoS One
Keywords
Brain Neoplasms, Cdc20 Proteins, Cell Cycle Proteins, Cell Line, Tumor, Glioblastoma, Humans, Neoplasm Recurrence, Local, Neoplastic Stem Cells
JAX Source
PLoS One 2022 Jun 23; 17(6):e0270251
Volume
17
Issue
6
First Page
0270251
Last Page
0270251
ISSN
1932-6203
PMID
35737702
DOI
https://doi.org/10.1371/journal.pone.0270251
Abstract
Glioblastoma stem cells (GSCs) are an important subpopulation in glioblastoma, implicated in tumor growth, tumor recurrence, and radiation resistance. Understanding the cellular mechanisms for chemo- and radiation resistance could lead to the development of new therapeutic strategies. Here, we demonstrate that CDC20 promotes resistance to chemotherapy and radiation therapy. CDC20 knockdown does not increase TMZ- and radiation-induced DNA damage, or alter DNA damage repair, but rather promotes cell death through accumulation of the pro-apoptotic protein, Bim. Our results identify a CDC20 signaling pathway that regulates chemo- and radiosensitivity in GSCs, with the potential for CDC20-targeted therapeutic strategies in the treatment of glioblastoma.
Recommended Citation
Mao D,
Cleary R,
Gujar A,
Mahlokozera T,
Kim A.
CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells. PLoS One 2022 Jun 23; 17(6):e0270251
Comments
This is an open access article under the CC BY-NC-ND license